Sponsor Pipeline

Beijing Konruns Pharmaceutical Co., Ltd. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
9
Active Trials
8
Recruiting
2
Phase 3
1
Disease Areas
Active Trials by Phase
Phase 3
2
Phase 2
3
Phase 1/2
1
Phase 1
3
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT06194734 A Study of KC1036 Versus Investigator's Choice of Chemotherapy in Patients With Advanced… Esophageal Squamous Cell Carcinoma Recruiting
NCT05970783 A Study of Jincaopian Tablets on Chronic Pelvic Pain After Pelvic Inflammatory Disease Chronic Pelvic Pain Recruiting
Phase 2
NCT06564272 A Study of KC1036 in Adolescents With Advanced Ewing Sarcoma Ewing Sarcoma Recruiting
NCT05683886 A Study of KC1036 in Patients with Advanced Thymic Tumors Thymic Tumors Recruiting
NCT07481058 KC1036 in Combination With PD-1 Antibody and Platinum-based Chemotherapy for First-line… Esophageal Squamous Cell Carcinoma (ESCC) Recruiting
Phase 1/2
NCT05260385 To Evaluate KC1036 in the Patients with Advanced Digestive System Tumors Digestive System Tumors Recruiting
Phase 1
NCT04093466 A Phase 1 Study of CX1003 (Kanitinib) in Patients with Advanced Solid Tumors Advanced Solid Tumor Recruiting
NCT04387916 A Study of KC1036 in Patients with Advanced Solid Tumors Advanced Solid Tumors Recruiting
NCT07118709 A Study of KC1086 in Patients With Advanced Solid Tumors Advanced Solid Tumors Cancer Not Yet Recruiting
Disease Areas
Get alerts when Beijing Konruns Pharmaceutical Co., Ltd.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free